Atai Life Sciences N.V.

NasdaqGM:ATAI Stock Report

Market Cap: US$331.5m

Atai Life Sciences Management

Management criteria checks 2/4

Atai Life Sciences' CEO is Florian Brand, appointed in Jun 2018, has a tenure of 5.83 years. total yearly compensation is $4.26M, comprised of 12.9% salary and 87.1% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth $955.02K. The average tenure of the management team and the board of directors is 1.4 years and 3.3 years respectively.

Key information

Florian Brand

Chief executive officer

US$4.3m

Total compensation

CEO salary percentage12.9%
CEO tenure5.8yrs
CEO ownership0.3%
Management average tenure1.4yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Is Atai Life Sciences (NASDAQ:ATAI) Using Debt Sensibly?

Mar 02
Is Atai Life Sciences (NASDAQ:ATAI) Using Debt Sensibly?

atai Life Sciences achieves positive results in phase 1 trial of kratom-derived drug

Oct 12

Atai Life Sciences: Decentralized Drug Discovery Platform

Oct 06

ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.01

Aug 15

We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Aug 07
We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Atai Life Sciences: Leading But Early Stage Psychedelic Therapeutics Developer

Jul 07

atai Life Sciences company Kures Therapeutics appoints Dr. Chad Beyer as CEO

Jun 30

Atai Life Sciences N.V.: A First Take

Jun 02

Atai Life Sciences And The Future Of Psychedelics For Mental Health

May 27

We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Apr 22
We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Florian Brand's remuneration changed compared to Atai Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$40m

Sep 30 2023n/an/a

-US$67m

Jun 30 2023n/an/a

-US$145m

Mar 31 2023n/an/a

-US$149m

Dec 31 2022US$4mUS$550k

-US$152m

Sep 30 2022n/an/a

-US$196m

Jun 30 2022n/an/a

-US$194m

Mar 31 2022n/an/a

-US$205m

Dec 31 2021US$27mUS$440k

-US$168m

Sep 30 2021n/an/a

-US$166m

Jun 30 2021n/an/a

-US$218m

Mar 31 2021n/an/a

-US$185m

Dec 31 2020US$12mUS$307k

-US$170m

Compensation vs Market: Florian's total compensation ($USD4.26M) is above average for companies of similar size in the US market ($USD2.39M).

Compensation vs Earnings: Florian's compensation has been consistent with company performance over the past year.


CEO

Florian Brand (36 yo)

5.8yrs

Tenure

US$4,256,331

Compensation

Mr. Florian Brand serves as Member of Executive Board at atai Life Sciences AG since July 2021. He served as Member of Supervisory Board at atai Life Sciences AG. until July 2021.He serves as Director at...


Leadership Team

NamePositionTenureCompensationOwnership
Christian Angermayer
Founder & Chairman of the Supervisory Boardno dataUS$222.96k2.49%
$ 8.2m
Florian Brand
Co-Founder5.8yrsUS$4.26m0.29%
$ 955.0k
Srinivas Rao
Co-Founder & Chief Scientific Officer5yrsUS$3.57m0.070%
$ 231.4k
Anne Johnson
Chief Financial Officerless than a yearno data0.044%
$ 145.7k
Michael Raven
Senior Vice President of Operationsless than a yearno datano data
Frank Stegert
Vice President of Investment & Venture Management3.3yrsno datano data
Ryan Barrett
Senior VP3.3yrsno datano data
Glenn Short
Senior Vice President of Early Developmentless than a yearno datano data
Sahil Kirpekar
Chief Business Officer1.4yrsno data0.038%
$ 127.1k
Kevin Craig
Senior Vice President of Clinical Developmentless than a yearno datano data

1.4yrs

Average Tenure

42yo

Average Age

Experienced Management: ATAI's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Christian Angermayer
Founder & Chairman of the Supervisory Board3.3yrsUS$222.96k2.49%
$ 8.2m
Sabrina Johnson
Independent Member of Supervisory Board3.3yrsUS$209.66k0%
$ 0
Amir Kalali
Independent Member of Supervisory Board3.3yrsUS$198.16k0.0028%
$ 9.2k
Andrea Smiley
Independent Member of Supervisory Board3.3yrsUS$214.46k0.0028%
$ 9.2k
Michael B. Auerbach
Independent Lead Member of Supervisory Board3.3yrsUS$222.96k0.31%
$ 1.0m
Jason Camm
Independent Member of Supervisory Board4.3yrsno datano data

3.3yrs

Average Tenure

51.5yo

Average Age

Experienced Board: ATAI's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.